On July 18, 2024, Zensar Technologies Limited announced via a stock exchange filing that its wholly owned subsidiary Zensar Technologies Inc., USA, has signed an agreement to acquire 100% ownership of BridgeView Life Sciences, LLC. Objectives and Impact of Acquisition The acquisition aims to bolster Zensar’s Healthcare and Life Sciences vertical. It enhances Zensar’s capabilities …